Financhill
Back

State Street SPDR SSGA Multi-Asset Real Return ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
64

RLY
State Street SPDR SSGA Multi-Asset Real Return ETF

Last Price:
$32.11
Seasonality Move:
-0.51%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$32.34
Seasonality Move:
-10.99%
Buy
64
State Street SPDR SSGA Multi-Asset Real Return ETF (RLY) is a Buy

Is State Street SPDR SSGA Multi-Asset Real Return ETF a Buy, Sell or Hold?

  • The current State Street SPDR SSGA Multi-Asset Real Return ETF [RLY] share price is $32.12. The Score for RLY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • RLY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RLY Stock Price Chart

What is State Street SPDR SSGA Multi-Asset Real Return ETF's stock price today?

  • The State Street SPDR SSGA Multi-Asset Real Return ETF share price today is $32.12
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RLY is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

RLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.09 Buy
Relative Strength Index (14 RSI): 61.96 Buy
Chaikin Money Flow: 88771 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.21 - 31.93) Buy
Bollinger Bands (100): (30.14 - 31.54) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

RLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.83 Buy
20-day SMA: 31.71 Buy
50-day SMA: 31.36 Buy
200-day SMA: 29.72 Buy
8-day EMA: 20.22 Buy
20-day EMA: 10.51 Buy
50-day EMA: 4.71 Buy
200-day EMA: 1.25 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

State Street SPDR SSGA Multi-Asset Real Return ETF Earnings Growth & RLY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

State Street SPDR SSGA Multi-Asset Real Return ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):